abstract |
The present invention relates to the use of at least one peptide having sequence VRLIVX1VRIX2RR (SEQ ID NO: 1, SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4), wherein X1 is selected from A or K and X2 is selected from W and K, as a bactericidal antimicrobial agent against Listeria monocytogenes. |